Literature DB >> 19751619

Ischemia-modified albumin in the diagnosis of pulmonary embolism: an experimental study.

Suleyman Turedi1, Tevfik Patan, Abdulkadir Gunduz, Ahmet Mentese, Celal Tekinbas, Murat Topbas, Suleyman Caner Karahan, Esin Yulug, Suha Turkmen, Utku Ucar.   

Abstract

STUDY
OBJECTIVE: We designed this experimental study to determine the value of ischemia-modified albumin in the diagnosis of pulmonary embolism.
METHODS: Twenty-four mature female New Zealand rabbits were divided into 4 groups, each consisting of 6 animals. These were classified into group 1 ,the control group; group 2, the deep venous thrombosis group; group 3, the deep venous thrombosis with pulmonary embolism group; and group 4, the pulmonary embolism-alone group. Deep venous thrombosis was produced by ligation of the iliac vein. To establish pulmonary embolism, 2 clots were administered from the iliac vein. Blood samples were taken from all the groups at hours 0, 1, 3, and 6 for ischemia-modified albumin measurement.
RESULTS: Pulmonary embolism was established in all the rabbits in groups 3 and 4, and this was confirmed by tomographic and histologic findings. Measurement of mean ischemia-modified albumin levels for all rabbits at hours 0, 1, 3, and 6 revealed that mean ischemia-modified albumin levels in groups 3 and 4 were statistically significantly higher than those in groups 1 and 2. There was no difference between the mean ischemia-modified albumin levels in groups 1 and 2 nor between groups 3 and 4. The alteration in ischemia-modified albumin levels over time was statistically significant.
CONCLUSIONS: The results of our experimental study demonstrate that ischemia-modified albumin levels may be useful in the diagnosis of pulmonary embolism.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19751619     DOI: 10.1016/j.ajem.2008.05.002

Source DB:  PubMed          Journal:  Am J Emerg Med        ISSN: 0735-6757            Impact factor:   2.469


  7 in total

1.  The protective effect of tadalafil on IMA (ischemia modified albumin) levels in experimental renal ischemia-reperfusion injury.

Authors:  Akin Soner Amasyali; Abdullah Akkurt; Ercan Kazan; Mustafa Yilmaz; Bulent Erol; Yuksel Yildiz; Haluk Erol
Journal:  Int J Clin Exp Med       Date:  2015-09-15

2.  Ischaemia modified albumin: Does it bolster our diagnostic ammunition?

Authors:  Dilip Gude; Ramesh Babu Byrapaneni
Journal:  Indian J Anaesth       Date:  2011-07

3.  Evaluation of ischemia-modified albumin and C-reactive protein in type 2 diabetics with and without ketosis.

Authors:  Shao-Gang Ma; Yao Jin; Wen Hu; Feng Bai; Wen Xu; Wei-Nan Yu
Journal:  Biomark Insights       Date:  2012-03-14

4.  The effect of single incision laparoscopic cholecystectomy on systemic oxidative stress: a prospective clinical trial.

Authors:  Ilhan Ece; Bahadir Ozturk; Huseyin Yilmaz; Serdar Yormaz; Mustafa Şahin
Journal:  Ann Surg Treat Res       Date:  2017-03-24       Impact factor: 1.859

5.  Construction of a Risk Prediction Model for Hospital-Acquired Pulmonary Embolism in Hospitalized Patients.

Authors:  Lengchen Hou; Longjun Hu; Wenxue Gao; Wenbo Sheng; Zedong Hao; Yiwei Chen; Jiyu Li
Journal:  Clin Appl Thromb Hemost       Date:  2021 Jan-Dec       Impact factor: 2.389

6.  Importance of oxidative stress in the evaluation of acute pulmonary embolism severity.

Authors:  Gülseren Sagcan; Dildar Konukoglu; Hafize Uzun; Orhan Arseven; Gulfer Okumus; Caglar Cuhadaroglu
Journal:  BMC Pulm Med       Date:  2022-10-17       Impact factor: 3.320

7.  Clinical significance of ischemia-modified albumin in the diagnosis of doxorubicin-induced myocardial injury in breast cancer patients.

Authors:  Yinghuan Ma; Wanjun Kang; Yongxin Bao; Fubin Jiao; Yiran Ma
Journal:  PLoS One       Date:  2013-11-04       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.